Outpatient Only

Brugada Syndrome (BrS) Panel

Synonyms

  • BRUGADA SYNDROME (BRS) PANEL
  • LAB11615

Cerner Name

Brugada Syndrome (BrS) Panel

Clinical Info

Confirmation of a clinical diagnosis in symptomatic patients
Risk assessment of asymptomatic family members of a proband with Brugada syndrome
Recurrence risk calculation
Differentiation of hereditary BrS from other acquired or genetic heart conditions
Prenatal diagnosis in families with a known mutation

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Specimen Volume

whole blood

Container

Lavender Top Tube or Buccal (Oral Cheek Swab)

Collection Instructions

Container/Tube: Lavender (EDTA) top tube
Specimen: whole blood
Transport Temperature: Room Temperature
 
Patient Genetic Consent form required with patient history indicated.

Transport Instructions

Room Temperature

Specimen Stability

Methodology

Deletion/Duplication Analysis
Next-Gen Sequencing
Genes:
ABCC9, CACNA1C, CACNA2D1, CACNB2, GPD1L, HCN4, KCND3, KCNE3, KCNH2, KCNJ8, PKP2, SCN10A, SCN1B, SCN2B, SCN3B, SCN5A, TRPM4

Days Performed

TAT: 4 Weeks

Performing Laboratories

GeneDx

CPT

81404,
81406 x 3,
81407,
81479 x 3

PDM

1659869

Results
Component Name Base Name Common Name External Name
BRUGADA SYNDROME (BRS) PANEL BRUGADA BRUGADA SYNDROME BRS PANEL Brugada Syndrome (BrS) Panel

Result Interpretation

Forms
Molecular-send outs LAB11615 build edit